VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-06-30 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-03-31 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-09-30 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 7.80K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2024-03-31 | 0.00 shares 10-K · filed 2024-05-31 | |
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | 0.00 shares 10-K · filed 2023-07-14 |
| 2022-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 0.00 shares derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-11 | 0.00 shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | 0.00 shares 10-K · filed 2022-06-10 |
| 2021-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | 0.00 shares derived: sum of 4 quarters · filed 2022-02-14 |
| 2021-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | 5.20K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-08-06 | 7.80K shares derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | 7.80K shares 10-K · filed 2021-06-15 |
| 2020-12-31 | 5.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | 7.80K shares derived: sum of 4 quarters · filed 2021-02-08 |
| 2020-09-30 | 2.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | 2.60K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-10 | 0.00 shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | 0.00 shares 10-K · filed 2020-05-28 |
| 2019-12-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | 0.00 shares derived: sum of 4 quarters · filed 2020-05-28 |
| 2019-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | 622.19K shares derived: sum of 4 quarters · filed 2020-05-28 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | 622.19K shares derived: sum of 4 quarters · filed 2020-05-28 |
| 2019-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | 622.19K shares 10-K · filed 2020-05-28 |
| 2018-12-31 | 622.19K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | 622.19K shares derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | 0.00 shares derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-06-30 | 0.00 shares 10-Q · filed 2018-08-09 | 500.00K shares derived: sum of 4 quarters · filed 2019-06-03 |
| 2018-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | 500.00K shares 10-K · filed 2019-06-03 |
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-02-08 | 500.00K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-09-30 | 500.00K shares 10-Q · filed 2017-11-09 | 539.00K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-06-30 | 0.00 shares 10-Q · filed 2017-08-09 | 245.27K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | 245.27K shares 10-K · filed 2018-05-31 |
| 2016-12-31 | 39.01K shares 10-Q · filed 2018-02-08 | 245.27K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-09-30 | 206.27K shares 10-Q · filed 2017-11-09 | 294.70K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-06-30 | 0.00 shares 10-Q · filed 2016-08-04 | 90.50K shares derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | 116.00K shares 10-K · filed 2018-05-31 |
| 2015-12-31 | 88.44K shares 10-Q · filed 2017-02-09 | 222.33K shares derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-09-30 | 2.06K shares 10-Q · filed 2016-11-03 | 144.50K shares derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-06-30 | 25.50K shares 10-Q · filed 2016-08-04 | 170.66K shares derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-03-31 | 106.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | 205.68K shares 10-K · filed 2017-06-07 |
| 2014-12-31 | 10.61K shares 10-Q · filed 2016-02-08 | 199.35K shares derived: sum of 4 quarters · filed 2016-02-08 |
| 2014-09-30 | 28.22K shares 10-Q · filed 2015-11-09 | 265.24K shares derived: sum of 4 quarters · filed 2015-11-09 |
| 2014-06-30 | 60.52K shares 10-Q · filed 2015-08-10 | 244.32K shares derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | 100.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09 | 183.80K shares 10-K · filed 2015-06-09 |
| 2013-12-31 | 76.50K shares 10-Q · filed 2015-02-06 | 1.01M shares derived: sum of 4 quarters · filed 2015-02-06 |
| 2013-09-30 | 7.30K shares 10-Q · filed 2014-11-07 | 935.28K shares derived: sum of 4 quarters · filed 2014-11-07 |
| 2013-06-30 | 0.00 shares 10-Q · filed 2014-08-08 | 2.35M shares derived: sum of 4 quarters · filed 2014-08-08 |
| 2013-03-31 | 927.98K shares 10-KT · filed 2013-05-24 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | 224.06K shares 10-K · filed 2014-06-10 |
| 2012-09-30 | 1.42M shares 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |